Akso Health Group

The Company operates as a healthcare equipment and product trading and related healthcare services business, primarily in China and the United States. Historically, the Company generated revenue from loan facilitation and post-origination services, which it disposed of on December 30, 2020. It then transitioned into a social e-commerce platform operator in China, which it disposed of in May 2023. Since the fourth quarter of 2021, the Company began exploring the healthcare sector. On January 4, 2022, it incorporated Akso Online Meditech in Wyoming, which sells COVID-19 Rapid Antigen test kits. In February 2022, Akso Online Meditech entered a supply agreement to purchase "iHealth" branded COVID-19 Rapid Antigen test kits and sells them to distributors in the United States. On January 26, 2022, the Company incorporated Qingdao Akso in Shandong Province, China, and began selling medical devices through it in April 2022. Qingdao Akso has supply agreements to purchase medical devices like defibrillators and anesthesia laryngoscopes, selling them to distributors or end-users in China. The Company has also advanced its presence in online hospital and chain pharmacies segments in China. In November 2024, it acquired Tianjin Wangyi Cloud Co., Ltd. and its wholly owned subsidiaries, Tianjin Deyihui Online Hospital Co., Limited and Tianjin Deyihui Clinic Co., Limited (collectively "Deyihui Group"), to strengthen its internet healthcare presence. The Company evaluates potential acquisitions of online hospitals in certain Chinese cities that provide online medical consultations for initial diagnosis, follow-up, and chronic disease management.